Results 21 to 30 of about 18,613 (202)

Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle‐based vaccine platform, for efficient viral antigen delivery

open access: yesJournal of Extracellular Vesicles, 2022
Vaccine platforms enable fast development, testing, and manufacture of more affordable vaccines. Here, we evaluated Generalized Modules for Membrane Antigens (GMMA), outer membrane vesicles (OMVs) generated by genetically modified Gram‐negative bacteria,
Kai Hu   +13 more
doaj   +1 more source

Modern approaches to production of safe and effective genetically modified rabies vaccines for animals

open access: yesВетеринария сегодня, 2023
Rabies is a dangerous zoonoticdisease that affects the central nervous system, causes encephalomyelitis and paralyses and Is almost invariably fatal.
M. I. Doronin   +6 more
doaj   +1 more source

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies

open access: yesFrontiers in Microbiology, 2022
The core element of the reindeer rabies eradication strategy is regular application of vaccines to obtain and uphold a vaccination coverage sufficient for the ceasing of rabies virus transmission.
Irina Matveeva   +11 more
doaj   +1 more source

BIOTECHNOLOGICAL RESEARCH IN THE CREATION AND PRODUCTION OF ANTIRABIC VACCINES [PDF]

open access: yesBiotechnologia Acta, 2021
Rabies is a neurological disease of a viral nature, leading to death. Rabies virus is an RNA virus that invades the central nervous system, leading to neuronal dysfunction. Timely vaccination can prevent the diseases development. Aim.
Krasnopolsky Yu. М., Pylypenko D. М.
doaj  

A Rabies Virus Glycoprotein Subunit Vaccine Produced in <i>Pichia pastoris</i> Induces Neutralizing Antibodies in Mice. [PDF]

open access: goldVaccines (Basel)
Yang Y   +11 more
europepmc   +2 more sources

Rabies virus glycoprotein produced in Nicotiana benthamiana is an immunogenic antigen in mice

open access: yesCzech Journal of Genetics and Plant Breeding, 2021
Rabies remains an infectious disease among humans and animals, and requires the development of an effective vaccine essential to prevent rabies. Advances in molecular biology and biotechnology have led to the development and improvement of many rabies ...
Youngmin Park   +10 more
doaj   +1 more source

New human rabies vaccines in the pipeline

open access: yesVaccine, 2019
Hildegund Ertl   +2 more
exaly   +2 more sources

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study

open access: yesHuman Vaccines & Immunotherapeutics, 2017
This phase IV, single blind study assessed the immunogenicity and safety of India-manufactured purified chick embryo cell rabies vaccine (PCECV), compared with a German-manufactured batch obtained by the same production process.
Gadey Sampath   +6 more
doaj   +1 more source

Studies on humoral immunity in dogs after use of rabies inactivated vaccines formulated with Montanide ISA 70 VG and GEL 01 adjuvants

open access: yesВетеринария сегодня, 2020
Despite all the efforts made, the issue of rabies in the world does not lose its relevance. As an acute endemic infection, it poses a considerable danger to both animals and humans.
A. N. Balashov   +5 more
doaj   +1 more source

Comparative effectiveness of liquid and freeze-dried vaccines for oral vaccination of dogs against rabies

open access: yesВетеринария сегодня, 2021
Currently, vaccination is the main measure to combat rabies in domestic and wild animals. Inactivated and live vaccines are used for this purpose. Oral vaccines for wild carnivores contain live attenuated rabies viruses in liquid or freeze-dried form ...
Z. D. Yershebulov   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy